(Q34048131)

30 July 2017

1 reference

title

Neuropsychologic assessment of patients for movement disorder surgery (English)

1 reference

30 July 2017

Saint-Cyr JA

1

1 reference

PubMed ID

11009179

30 July 2017

Trépanier LL

series ordinal

2

1 reference

PubMed ID

11009179

30 July 2017

language of work or name

English

0 references

publication date

1 September 2000

1 reference

30 July 2017

1 reference

30 July 2017

15

1 reference

30 July 2017

5

1 reference

30 July 2017

771-783

1 reference

Cognitive function in Parkinson's disease: From description to theory

30 July 2017

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

Cognitive deficits in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

Frontal lobe dysfunction in Parkinson's disease. The cortical focus of neostriatal outflow

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

Fronto-striatal cognitive deficits at different stages of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

Bilateral subthalamic or pallidal stimulation for Parkinson's disease affects neither memory nor executive functions: a consecutive series of 62 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

The impact of lesion laterality on neuropsychological change following posterior pallidotomy: a review of current findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

Cognitive and behavioral changes after unilateral posteroventral pallidotomy: relationship with lesional data from MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

Neuropsychological consequences of posteroventral pallidotomy for the treatment of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

Impaired frontostriatal cognitive functioning following posteroventral pallidotomy in advanced Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

Cognitive outcome after unilateral pallidal stimulation in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

Neuropsychological, neurological and functional outcome following pallidotomy for Parkinson's disease. A consecutive series of eight simultaneous bilateral and twelve unilateral procedures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

'Frontal' cognitive function in patients with Parkinson's disease 'on' and 'off' levodopa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

Parkinson's disease. Cognitive changes in relation to treatment response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

Posteroventral medial pallidotomy in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

Parkinson's disease. Second of two parts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

Parkinson's disease. First of two parts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

Posteroventral medial pallidotomy in levodopa-unresponsive parkinsonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

Posteroventral medial pallidotomy in advanced Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

Preoperative indicators of clinical outcome following stereotaxic pallidotomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

A data-driven approach to the study of heterogeneity in idiopathic Parkinson's disease: identification of three distinct subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

A brief assessment of frontal and subcortical functions in dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

Mini-Mental Parkinson: first validation study of a new bedside test constructed for Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

Differential diagnosis of parkinsonism with [18F]fluorodeoxyglucose and PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

Proton magnetic resonance spectroscopic imaging in progressive supranuclear palsy, Parkinson's disease and corticobasal degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

A clinicopathologic study of 100 cases of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

Memory and language in neurodegenerative diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

Neuropsychological characteristics of preclinical dementia in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

Cognitive, neuroimaging, and pathological studies in a patient with Pick's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

A review of Lewy body disease, an emerging concept of cortical dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

A preliminary investigation of laterality in Parkinson's disease and susceptibility to psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

Visual loss in Alzheimer's disease: out of sight, out of mind.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

Depression and Parkinson's disease: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

Cognitive impairments and depression in Parkinson's disease: a follow up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

Parkinson's disease and depression. A critical re-evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

Neuropsychological impairment in Parkinson's disease with and without depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

A study of familial aggregation of depression, dementia and Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

Personality, depression, and premorbid lifestyle in twin pairs discordant for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

Parkinson's disease and depression: evidence for an alteration of the basal limbic system detected by transcranial sonography

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

Studies of dementia, depression, electrophysiology and cerebrospinal fluid monoamine metabolites in patients with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

Depression in Parkinson's disease: a biochemical model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

Improvement in laryngeal dystonia with background noise

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

21 January 2018

Hypoxia versus ischemia.

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

A controlled investigation of current and premorbid personality: characteristics of Parkinson's disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

The neuropsychology of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

Efficiency and safety of bilateral contemporaneous pallidal stimulation (deep brain stimulation) in levodopa-responsive patients with Parkinson's disease with severe motor fluctuations: a 2-year follow-up review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

Unilateral pallidotomy for Parkinson's disease: comparison of outcome in younger versus elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

Different effects of dopaminergic and anticholinergic therapies on cognitive and motor function in Parkinson's disease. A follow-up study of untreated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

L-dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

Effect of GPi pallidotomy on motor function in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

The effect of unilateral posteroventral pallidotomy on the kinematics of the reach to grasp movement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

Movement and reaction times and fine coordination tasks following pallidotomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

The effects of posteroventral pallidotomy on the preparation and execution of voluntary hand and arm movements in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

Neuropsychological and behavioral changes and weight gain after medial pallidotomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

Unilateral radiofrequency lesion versus electrostimulation of posteroventral pallidum: a prospective randomized comparison.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

Neurocognitive and psychosocial correlates of ventroposterolateral pallidotomy surgery in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

Hemisphere-specific cognitive and motor changes after unilateral posteroventral pallidotomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

Unilateral pallidal stimulation for Parkinson's disease: neurobehavioral functioning before and 3 months after electrode implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

Neuropsychological outcome following unilateral pallidotomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

A comparison of phonemic, semantic, and alternating word fluency in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

Letter and Semantic Fluency in Alzheimer's, Huntington's, and Parkinson's Dementias

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

Motor, cognitive, and behavioral performance following unilateral ventroposterior pallidotomy for Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

Working memory in medicated patients with Parkinson's disease: the central executive seems to work

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

Paced auditory serial-addition task: a measure of recovery from concussion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

The differential effects of cueing on recall in Parkinson's disease and normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

Memory and learning in early Parkinson's disease: evidence for a "frontal lobe syndrome".

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

Abnormal basal ganglia outflow in Parkinson's disease identified with PET. Implications for higher cortical functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

The effect of Parkinson's disease on the ability to maintain a mental set.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

Procedural learning and neostriatal dysfunction in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

The behavioural and motor consequences of focal lesions of the basal ganglia in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

Frontal-subcortical circuits and human behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

Neuropsychiatric correlates and treatment of lenticulostriatal diseases: a review of the literature and overview of research opportunities in Huntington's, Wilson's, and Fahr's diseases. A report of the ANPA Committee on Research. American Neuropsyc

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

Frontal-subcortical circuits and neuropsychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

The psychology of perserverative and stereotyped behaviour

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

Assessing frontal lobe behavioral syndromes with the frontal lobe personality scale.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

Treatment strategies for patients with dysexecutive syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

Personality correlates of [18F]dopa striatal uptake: results of positron-emission tomography in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C771%3A%3AAID-MDS1003%3E3.0.CO%3B2-Y

10.1002/1531-8257(200009)15:5<771::AID-MDS1003>3.0.CO;2-Y

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

11009179